FDA inspection
Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd.: FDA inspection ending Jun 21, 2017
FDA inspection 1018289 · Official Action Indicated (OAI) · Fengxian District
Key facts
| Inspection ID | 1018289 |
|---|---|
| Firm | Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd. |
| FEI number | 3002806569 |
| Address | No. 3 Baiyunlu, Fengxian |
| City | Fengxian District |
| Country | China |
| Fiscal year | 2017 |
| Inspection end date | Jun 21, 2017 |
| Classification | Official Action Indicated (OAI) |
| Project area | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| Product type | Veterinary |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data